Amy GilesIncreasing Engagement
David LinetskyPoint-of-Care Marketing
Matt TurnerPatient Affordability
Frank BurrellScientific Storytelling
Matthew DurhamOmnidynamic Marketing
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
Pat PurcellMeeting Engagement
Paul TheisenPatient Acquisition
Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
Liz KaneImpactful Strategy
Joey CohenMedication Adherence
Bud BilanichSuccess Coach
ZEJULA is the #1 PARP inhibitor for women with ovarian cancer in the U.S.2017 ...
Interim data expected by end of 201712 April 2017 Breda, the Netherlands/Ghent, Belgium - ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email